Literature DB >> 2463607

Course of symptoms and spontaneous ECG in pacemaker patients: a 5-year follow-up study.

H Langenfeld1, W Grimm, B Maisch, K Kochsiek.   

Abstract

We investigated the course of symptoms and the spontaneous ECG retrospectively in 308 patients who had received a pacemaker because of atrioventricular (AV) block (n = 115), sick sinus syndrome (SSS, n = 107), bradyarrhythmic atrial fibrillation (bradyarrhythmia, n = 51), carotid sinus syndrome (CSS, n = 16), complete bifascicular block associated with 1st degree AV block (n = 13) and with other indications (n = 6). The mean implantation time was 63 months. The clinical state of 93% of all patients improved after pacemaker implantation; their symptoms decreased markedly. Persisting syncopy in some patients with SSS, however, supports a restricted implantation policy. We rarely saw improved AV conduction in patients with AV block (11%). Furthermore, in patients with SSS, atrial fibrillation occurred significantly more often (35%) than in those with AV block (17%; P less than 0.01). Only 3% of patients with SSS developed 2nd and 3rd degree AV block within the observation period. In all patients with initial bifascicular block and additional 1st degree AV block, pacing prevented further syncopal attacks; four of them showed 3rd degree AV block at control, indicating that pacemaker implantation is mandatory in symptomatic patients with bifascicular disease and 1st degree AV block.

Entities:  

Mesh:

Year:  1988        PMID: 2463607     DOI: 10.1111/j.1540-8159.1988.tb05986.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  7 in total

Review 1.  Pacing in neurocardiogenic/vasovagal syncope.

Authors:  Richard Sutton
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-05-25

2.  Syncope in Patients with Pacemakers.

Authors:  Richard Sutton
Journal:  Arrhythm Electrophysiol Rev       Date:  2015-12-01

Review 3.  Pacing in vasovagal syncope: Physiology, pacemaker sensors, and recent clinical trials-Precise patient selection and measurable benefit.

Authors:  Richard Sutton; Jelle S Y de Jong; Julian M Stewart; Artur Fedorowski; Frederik J de Lange
Journal:  Heart Rhythm       Date:  2020-02-06       Impact factor: 6.343

Review 4.  Syncope and paroxysmal atrioventricular block.

Authors:  Milena Aste; Michele Brignole
Journal:  J Arrhythm       Date:  2017-05-08

5.  Pacing therapy in the management of unexplained syncope: a tertiary care centre prospective study.

Authors:  Ekrem Yasa; Fabrizio Ricci; Hannes Holm; Torbjörn Persson; Olle Melander; Richard Sutton; Viktor Hamrefors; Artur Fedorowski
Journal:  Open Heart       Date:  2019-03-25

6.  Cardiovascular Autonomic Dysfunction Is the Most Common Cause of Syncope in Paced Patients.

Authors:  Ekrem Yasa; Fabrizio Ricci; Hannes Holm; Torbjörn Persson; Olle Melander; Richard Sutton; Artur Fedorowski; Viktor Hamrefors
Journal:  Front Cardiovasc Med       Date:  2019-10-25

7.  Long-Term Technical Performance of the Osypka QT-5® Ventricular Pacemaker Lead.

Authors:  Georg Semmler; Fabian Barbieri; Karin Thudt; Paul Vock; Deddo Mörtl; Harald Mayr; Christian Georg Wollmann; Agne Adukauskaite; Bernhard Pfeifer; Thomas Senoner; Wolfgang Dichtl
Journal:  J Clin Med       Date:  2021-02-08       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.